---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-21-000626"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2021-12-20T23:59:59+00:00"
generated_at: "2026-06-27T23:42:32.915819+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma pays down $1.02M of convertible notes, principal now $1.34M

## Summary
- Principal indebtedness on convertible notes reduced from $2,364,075 (Jun 30) to $1,340,621 (Dec 13, 2021).
- Company satisfied $1,023,454 of principal debt between July 1 and Dec 13, 2021.
- This represents a 43% reduction in principal debt over approximately 5.5 months.

## SEC filing metadata
- accession: 0001607062-21-000626
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2021-12-20T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000626/0001607062-21-000626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000626/rgbp122021form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-21-000626
- JSON: https://secwatch.observer/filing/0001607062-21-000626.json
- Plain text: https://secwatch.observer/filing/0001607062-21-000626.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.